These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of Academic Drug Discovery in the Quest for New CNS Therapeutics. Yokley BH; Hartman M; Slusher BS ACS Chem Neurosci; 2017 Mar; 8(3):429-431. PubMed ID: 28195461 [TBL] [Abstract][Full Text] [Related]
3. New frontiers for collaborative research. Goldman M Sci Transl Med; 2013 Dec; 5(216):216ed22. PubMed ID: 24353157 [No Abstract] [Full Text] [Related]
4. The role of public-private partnerships in addressing the biomedical innovation challenge. Said M; Zerhouni E Nat Rev Drug Discov; 2014 Nov; 13(11):789-90. PubMed ID: 25359362 [TBL] [Abstract][Full Text] [Related]
5. Competition: Unlikely partnerships. Savage N Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391 [No Abstract] [Full Text] [Related]
6. Is pharma running out of brainy ideas? Miller G Science; 2010 Jul; 329(5991):502-4. PubMed ID: 20671165 [No Abstract] [Full Text] [Related]
7. Universities shun Europe's drug initiative. Gilbert N Nature; 2010 Jul; 466(7304):306-7. PubMed ID: 20631770 [No Abstract] [Full Text] [Related]
8. Proceedings of the 2013 CINP summit: innovative partnerships to accelerate CNS drug discovery for improved patient care. Phillips AG; Hongaard-Andersen P; Moscicki RA; Sahakian B; Quirion R; Krishnan KR; Race T Int J Neuropsychopharmacol; 2014 Dec; 18(3):. PubMed ID: 25542690 [TBL] [Abstract][Full Text] [Related]
9. Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare. Wellenreuther R; Keppler D; Mumberg D; Ziegelbauer K; Lessl M Drug Discov Today; 2012 Nov; 17(21-22):1242-8. PubMed ID: 22521665 [TBL] [Abstract][Full Text] [Related]
10. New collaboration aims to aid target validation and drive drug discovery. Wilson H Pharmacogenomics; 2014 Apr; 15(6):732. PubMed ID: 25022024 [No Abstract] [Full Text] [Related]
11. Four disruptive strategies for removing drug discovery bottlenecks. Ekins S; Waller CL; Bradley MP; Clark AM; Williams AJ Drug Discov Today; 2013 Mar; 18(5-6):265-71. PubMed ID: 23098820 [TBL] [Abstract][Full Text] [Related]
12. The innovative medicines initiative: a European response to the innovation challenge. Goldman M Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619 [TBL] [Abstract][Full Text] [Related]
13. Drug development partnerships look set to grow. Watts G Lancet; 2016 Jul; 388(10039):16-8. PubMed ID: 27397780 [No Abstract] [Full Text] [Related]
14. Allocation of control rights and cooperation efficiency in public-private partnerships: theory and evidence from the Chinese pharmaceutical industry. Zhang Z; Jia M; Wan D Int J Health Care Finance Econ; 2009 Jun; 9(2):169-82. PubMed ID: 19360467 [TBL] [Abstract][Full Text] [Related]
15. Improving R&D productivity of pharmaceutical companies through public-private partnership: experiences from the Innovative Medicines Initiative. Laverty H; Gunn M; Goldman M Expert Rev Pharmacoecon Outcomes Res; 2012 Oct; 12(5):545-8. PubMed ID: 23136843 [No Abstract] [Full Text] [Related]
16. Public-private partnerships to revitalize psychiatric drug discovery. Brady LS; Potter WZ Expert Opin Drug Discov; 2014 Jan; 9(1):1-8. PubMed ID: 24308355 [TBL] [Abstract][Full Text] [Related]
17. Global strategic partnerships in regenerative medicine. French A; Suh JY; Suh CY; Rubin L; Barker R; Bure K; Reeve B; Brindley DA Trends Biotechnol; 2014 Sep; 32(9):436-40. PubMed ID: 25150363 [TBL] [Abstract][Full Text] [Related]
18. Crowdsourcing in pharma: a strategic framework. Bentzien J; Bharadwaj R; Thompson DC Drug Discov Today; 2015 Jul; 20(7):874-83. PubMed ID: 25637169 [TBL] [Abstract][Full Text] [Related]
19. Re-engineering drug discovery and development. FitzGerald GA LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582 [TBL] [Abstract][Full Text] [Related]